These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 19273463)

  • 1. Impact of pharmaceutical representative visits on GPs' drug preferences.
    Søndergaard J; Vach K; Kragstrup J; Andersen M
    Fam Pract; 2009 Jun; 26(3):204-9. PubMed ID: 19273463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detailed postal feedback about prescribing to asthma patients combined with a guideline statement showed no impact: a randomised controlled trial.
    Søndergaard J; Andersen M; Vach K; Kragstrup J; Maclure M; Gram LF
    Eur J Clin Pharmacol; 2002 May; 58(2):127-32. PubMed ID: 12012145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in prescribing between GPs: impact of the cooperation with pharmacists and impact of visits from pharmaceutical industry representatives.
    Muijrers PE; Grol RP; Sijbrandij J; Janknegt R; Knottnerus JA
    Fam Pract; 2005 Dec; 22(6):624-30. PubMed ID: 16055474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of a complex intervention for changing professional behaviour: the Evidence Based Out Reach (EBOR) Trial.
    Nazareth I; Freemantle N; Duggan C; Mason J; Haines A
    J Health Serv Res Policy; 2002 Oct; 7(4):230-8. PubMed ID: 12425782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promotional methods used by representatives of drug companies: a prospective survey in general practice.
    Schramm J; Andersen M; Vach K; Kragstrup J; Kampmann JP; Søndergaard J
    Scand J Prim Health Care; 2007 Jun; 25(2):93-7. PubMed ID: 17497486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding why GPs see pharmaceutical representatives: a qualitative interview study.
    Prosser H; Walley T
    Br J Gen Pract; 2003 Apr; 53(489):305-11. PubMed ID: 12879831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of pharmacotherapy audit meetings on early new drug prescribing by general practitioners.
    Florentinus SR; van Hulten R; Kloth ME; Heerdink ER; Griens AM; Leufkens HG; Groenewegen PP;
    Ann Pharmacother; 2007 Feb; 41(2):319-24. PubMed ID: 17244644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of pharmaceutical promotion on prescribing decisions of general practitioners in Eastern Turkey.
    Vancelik S; Beyhun NE; Acemoglu H; Calikoglu O
    BMC Public Health; 2007 Jun; 7():122. PubMed ID: 17592644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of co-morbidity on GPs' pharmacological treatment decisions for patients with an anxiety disorder.
    Smolders M; Laurant M; van Rijswijk E; Mulder J; Braspenning J; Verhaak P; Wensing M; Grol R
    Fam Pract; 2007 Dec; 24(6):538-46. PubMed ID: 18003604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of the prescribing of potentially inappropriate medications at ambulatory care visits by elderly patients covered by the Taiwanese National Health Insurance program.
    Lai HY; Hwang SJ; Chen YC; Chen TJ; Lin MH; Chen LK
    Clin Ther; 2009 Aug; 31(8):1859-70. PubMed ID: 19808145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How conducting a clinical trial affects physicians' guideline adherence and drug preferences.
    Andersen M; Kragstrup J; Søndergaard J
    JAMA; 2006 Jun; 295(23):2759-64. PubMed ID: 16788131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Attitudes of general practitioners to pharmaceutical sales representatives in Sousse].
    Ben Abdelaziz A; Harrabi I; Rahmani S; Ghedira A; Gaha K; Ghannem H
    East Mediterr Health J; 2003; 9(5-6):1075-83. PubMed ID: 16450540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of computer reminders on GPs' prescribing behaviour: a cluster-randomised trial.
    Martens JD; van der Weijden T; Severens JL; de Clercq PA; de Bruijn DP; Kester AD; Winkens RA
    Int J Med Inform; 2007 Dec; 76 Suppl 3():S403-16. PubMed ID: 17569575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Drug marketing: methods, effect and regulation].
    Søndergaard J; Koefoed MM; Andersen M
    Ugeskr Laeger; 2009 Mar; 171(10):778-80. PubMed ID: 19265598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Drug prescription in general practice. A descriptive examination in solo practice in the former county of Roskilde].
    Schaefer K; Henriksen LO; Munck A; Damgaard J
    Ugeskr Laeger; 2008 Jun; 170(26-32):2327-30. PubMed ID: 18570765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinants of the range of drugs prescribed in general practice: a cross-sectional analysis.
    de Bakker DH; Coffie DS; Heerdink ER; van Dijk L; Groenewegen PP
    BMC Health Serv Res; 2007 Aug; 7():132. PubMed ID: 17711593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multifaceted intervention according to the Audit Project Odense method improved secondary prevention of ischemic heart disease: a randomised controlled trial.
    Søndergaard J; Hansen DG; Aarslev P; Munck AP
    Fam Pract; 2006 Apr; 23(2):198-202. PubMed ID: 16243954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient awareness and concern regarding pharmaceutical manufacturer interactions with doctors.
    Edwards D; Ballantyne A
    Intern Med J; 2009 Mar; 39(3):191-6. PubMed ID: 19383067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of educational outreach visits on prescribing of benzodiazepines and antipsychotic drugs to elderly patients in primary health care in southern Sweden.
    Midlöv P; Bondesson A; Eriksson T; Nerbrand C; Höglund P
    Fam Pract; 2006 Feb; 23(1):60-4. PubMed ID: 16332945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What information do physicians receive from pharmaceutical representatives?
    Lexchin J
    Can Fam Physician; 1997 May; 43():941-5. PubMed ID: 9154366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.